• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

局部用肉毒杆菌毒素。

Topical botulinum toxin.

作者信息

Collins Ashley, Nasir Adnan

出版信息

J Clin Aesthet Dermatol. 2010 Mar;3(3):35-9.

PMID:20725542
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2921740/
Abstract

Nanotechnology is a rapidly growing discipline that capitalizes on the unique properties of matter engineered on the nanoscale. Vehicles incorporating nanotechnology have led to great strides in drug delivery, allowing for increased active ingredient stability, bioavailability, and site-specific targeting. Botulinum toxin has historically been used for the correction of neurological and neuromuscular disorders, such as torticollis, blepharospasm, and strabismus. Recent dermatological indications have been for the management of axillary hyperhydrosis and facial rhytides. Traditional methods of botulinum toxin delivery have been needle-based. These have been associated with increased pain and cost. Newer methods of botulinum toxin formulation have yielded topical preparations that are bioactive in small pilot clinical studies. While there are some risks associated with topical delivery, the refinement and standardization of delivery systems and techniques for the topical administration of botulinum toxin using nanotechnology is anticipated in the near future.

摘要

纳米技术是一门迅速发展的学科,它利用在纳米尺度上设计的物质的独特性质。包含纳米技术的载体在药物递送方面取得了巨大进展,提高了活性成分的稳定性、生物利用度,并实现了位点特异性靶向。肉毒杆菌毒素一直以来被用于治疗神经和神经肌肉疾病,如斜颈、眼睑痉挛和斜视。最近在皮肤科领域的应用是治疗腋窝多汗症和面部皱纹。传统的肉毒杆菌毒素递送方法是基于针头的。这些方法伴随着疼痛加剧和成本增加的问题。新型肉毒杆菌毒素制剂已产生了在小型先导临床研究中具有生物活性的局部用制剂。虽然局部递送存在一些风险,但预计在不久的将来,利用纳米技术进行肉毒杆菌毒素局部给药的递送系统和技术将得到改进和标准化。

相似文献

1
Topical botulinum toxin.局部用肉毒杆菌毒素。
J Clin Aesthet Dermatol. 2010 Mar;3(3):35-9.
2
Review of the FDA-approved uses of botulinum toxins, including data suggesting efficacy in pain reduction.美国食品药品监督管理局(FDA)批准的肉毒杆菌毒素用途综述,包括表明其在减轻疼痛方面有效性的数据。
Clin J Pain. 2002 Nov-Dec;18(6 Suppl):S142-6. doi: 10.1097/00002508-200211001-00005.
3
[Use of botulinum toxin in ophthalmology].[肉毒杆菌毒素在眼科中的应用]
Klin Monbl Augenheilkd. 1997 May;210(5):289-92. doi: 10.1055/s-2008-1035054.
4
Botulinum A toxin (Oculinum) in ophthalmology.眼科中的A型肉毒杆菌毒素(奥曲肽)
Surv Ophthalmol. 1991 Jul-Aug;36(1):28-46. doi: 10.1016/0039-6257(91)90207-v.
5
Botulinum toxin type-A preparations are not the same medications - clinical studies (Part 2).A型肉毒毒素制剂并非同一种药物——临床研究(第二部分)。
Neurol Neurochir Pol. 2021;55(2):141-157. doi: 10.5603/PJNNS.a2021.0028. Epub 2021 Apr 2.
6
Botulinum-A toxin in the treatment of craniocervical muscle spasms: short- and long-term, local and systemic effects.肉毒杆菌A毒素治疗颅颈肌痉挛:短期和长期的局部及全身影响
Surv Ophthalmol. 1996 Jul-Aug;41(1):51-65. doi: 10.1016/s0039-6257(97)81995-9.
7
Use of botulinum toxin in neuro-ophthalmology.肉毒杆菌毒素在神经眼科中的应用。
Curr Opin Ophthalmol. 2001 Dec;12(6):419-22. doi: 10.1097/00055735-200112000-00006.
8
Botulinum toxin in the treatment of paralytic strabismus and essential blepharospasm.肉毒杆菌毒素治疗麻痹性斜视和特发性眼睑痉挛。
Indian J Ophthalmol. 1993 Oct;41(3):121-4.
9
Use of Botulinum Toxin in Ophthalmology.肉毒杆菌毒素在眼科中的应用。
Handb Exp Pharmacol. 2021;263:147-160. doi: 10.1007/164_2019_325.
10
Botulinum toxin therapy for neurologic disorders.用于神经系统疾病的肉毒杆菌毒素疗法。
Postgrad Med. 1992 May 1;91(6):327-32, 334. doi: 10.1080/00325481.1992.11701332.

引用本文的文献

1
Use of Botulinum Toxin in Treating Rosacea: A Systematic Review.肉毒杆菌毒素在治疗酒渣鼻中的应用:一项系统评价。
Clin Cosmet Investig Dermatol. 2021 Apr 30;14:407-417. doi: 10.2147/CCID.S307013. eCollection 2021.
2
Alternative Methods for Testing Botulinum Toxin: Current Status and Future Perspectives.肉毒杆菌毒素检测的替代方法:现状与未来展望
Biomol Ther (Seoul). 2020 Jul 1;28(4):302-310. doi: 10.4062/biomolther.2019.200.
3
Efficacy of Intralesional Botulinum Toxin A for Treatment of Painful Cutaneous Leiomyomas: A Randomized Clinical Trial.病灶内注射A型肉毒杆菌毒素治疗疼痛性皮肤平滑肌瘤的疗效:一项随机临床试验。
JAMA Dermatol. 2015 Oct;151(10):1096-102. doi: 10.1001/jamadermatol.2015.1793.

本文引用的文献

1
Novel topical BoNTA (CosmeTox, toxin type A) cream used to treat hyperfunctional wrinkles of the face, mouth, and neck.新型局部注射肉毒杆菌毒素A(CosmeTox,A型毒素)乳膏用于治疗面部、口腔和颈部的功能亢进性皱纹。
Aesthetic Plast Surg. 2008 Sep;32(5):715-22; discussion 723. doi: 10.1007/s00266-008-9151-9. Epub 2008 May 15.
2
Dermatologic toxicity of nanoengineered materials.
Arch Dermatol. 2008 Feb;144(2):253-4. doi: 10.1001/archdermatol.2007.60.
3
Pharmacology of therapeutic botulinum toxin preparations.治疗用肉毒杆菌毒素制剂的药理学
Disabil Rehabil. 2007 Dec 15;29(23):1761-8. doi: 10.1080/09638280701568296.
4
Bone loss after temporarily induced muscle paralysis by Botox is not fully recovered after 12 weeks.
Ann N Y Acad Sci. 2007 Nov;1116:444-60. doi: 10.1196/annals.1402.009. Epub 2007 Jun 21.
5
Topically applied botulinum toxin type A for the treatment of primary axillary hyperhidrosis: results of a randomized, blinded, vehicle-controlled study.局部应用A型肉毒杆菌毒素治疗原发性腋窝多汗症:一项随机、双盲、赋形剂对照研究的结果
Dermatol Surg. 2007 Jan;33(1 Spec No.):S76-80. doi: 10.1111/j.1524-4725.2006.32335.x.
6
Update on botulinum toxin.肉毒杆菌毒素的最新情况。
Semin Cutan Med Surg. 2006 Sep;25(3):115-21. doi: 10.1016/j.sder.2006.06.003.
7
Psychosocial aspects of botox in aesthetic surgery.
Aesthetic Plast Surg. 2006 Jan-Feb;30(1):71-6. doi: 10.1007/s00266-005-0150-9.
8
Botulinal neurotoxins: revival of an old killer.肉毒杆菌神经毒素:一种古老杀手的复苏。
Curr Opin Pharmacol. 2005 Jun;5(3):274-9. doi: 10.1016/j.coph.2004.12.006.
9
Botulinum toxin: mechanisms of action.肉毒杆菌毒素:作用机制
Arq Neuropsiquiatr. 2005 Mar;63(1):180-5. doi: 10.1590/s0004-282x2005000100035. Epub 2005 Apr 13.
10
Botulinum toxin types A and B: comparison of efficacy, duration, and dose-ranging studies for the treatment of facial rhytides and hyperhidrosis.A型和B型肉毒杆菌毒素:用于治疗面部皱纹和多汗症的疗效、持续时间及剂量范围研究的比较
Clin Dermatol. 2004 Jan-Feb;22(1):34-9. doi: 10.1016/j.clindermatol.2003.11.005.